SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-020826
Filing Date
2020-11-09
Accepted
2020-11-09 16:25:31
Documents
15
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.htm   iXBRL 8-K 37352
2 ex99-1.htm EX-99.1 15992
3 ex99-2.htm EX-99.2 71133
4 ex99-1_001.jpg GRAPHIC 18210
  Complete submission text file 0001493152-20-020826.txt   346585

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE hrow-20201109.xsd EX-101.SCH 3189
6 XBRL LABEL FILE hrow-20201109_lab.xml EX-101.LAB 35273
7 XBRL PRESENTATION FILE hrow-20201109_pre.xml EX-101.PRE 23148
8 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3776
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 201298073
SIC: 2834 Pharmaceutical Preparations